1015 studies found for:    "Hodgkin Disease"
Show Display Options
RSS Create an RSS feed from your search for:
"Hodgkin Disease"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients
Conditions: Hodgkin Lymphoma;   Hodgkin Disease
Intervention: Drug: triptorelin
2 Completed Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial
Conditions: Hodgkin's Disease;   Lymphoma
Intervention:
3 Completed Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease
Conditions: Lymphoma, Hodgkin Disease;   Lymphoma;   Hodgkin Disease;   Lymphoma: Hodgkin
Interventions: Drug: Gemcitabine;   Drug: Vinorelbine;   Drug: Carmustine;   Drug: Etoposide;   Drug: Cyclophosphamide;   Procedure: Autologous hematopoietic stem cell transplantation.
4 Unknown  Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease
Condition: Hodgkin's Disease
Interventions: Drug: R-mabHD;   Drug: ABVD
5 Completed Mantle Irradiation for Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Procedure: Mantle irradiation
6 Completed Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors
Conditions: Hodgkin's Disease;   Breast Cancer
Intervention: Drug: Tamoxifen
7 Terminated Breast-Sparing Proton Therapy for Hodgkin's Disease
Condition: Hodgkins Disease
Intervention: Radiation: Proton
8 Recruiting Personalised Program for Women Treated for Hodgkin Disease
Conditions: Hodgkin Disease;   Breast Cancer
Intervention: Procedure: intensive screening
9 Completed Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease
Conditions: HIV Infections;   Hodgkin's Disease
Interventions: Drug: Vinblastine sulfate;   Drug: Dacarbazine;   Drug: Filgrastim;   Drug: Bleomycin sulfate;   Drug: Doxorubicin hydrochloride
10 Terminated Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease
Conditions: B-Cell Lymphoma;   Hodgkin's Disease
Intervention: Drug: Thalidomide
11 Recruiting Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease
Condition: Hodgkin's Disease
Interventions: Drug: Gemcitabine;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Antithymocyte Globulin;   Procedure: Allogeneic Stem Cell Infusion;   Drug: Tacrolimus;   Drug: Filgrastim (G-CSF);   Drug: Methotrexate
12 Active, not recruiting Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease
Conditions: Lymphoma;   Hodgkin's Disease
Interventions: Drug: Melphalan;   Drug: Ara-C;   Drug: VP-16;   Drug: BCNU;   Drug: Rituxan;   Drug: Stem Cells
13 Completed Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)
Condition: Hodgkin's Disease
Interventions: Drug: Methotrexate;   Drug: Leucovorin calcium;   Drug: 6-Thioguanine
14 Completed Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade
Conditions: Hodgkin's Disease;   Malignant Lymphomas High Grade;   Chemoresistance
Intervention: Procedure: TEP au MIBI
15 Completed
Has Results
AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Drug: G-CSF Plus Plerixafor
16 Terminated
Has Results
Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease
Conditions: Hodgkin's Disease;   Lymphoma
Intervention: Drug: Alemtuzumab (Campath-1H)
17 Completed A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)
Conditions: Pediatric;   Hodgkin's Disease
Interventions: Drug: COPP/ABV;   Drug: intensive chemo with concurrent growth factor
18 Completed A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Drug: MDX-060
19 Completed Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy
Condition: Hodgkin Disease
Interventions: Drug: Filgrastim SD/01;   Drug: Adriamycin;   Drug: Bleomycin;   Drug: Vinblastine;   Drug: DTIC
20 Active, not recruiting Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma
Conditions: Lymphoma, Hodgkin Disease;   Lymphoma;   Hodgkin Disease;   Lymphoma: Hodgkin
Interventions: Drug: bleomycin;   Drug: cyclophosphamide;   Drug: prednisone;   Drug: vincristine;   Drug: Adriamycin;   Drug: Velban;   Drug: VP-16

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years